| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ibio, Inc. (IBIO) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. IBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 479.0K | $785.6K | - | |
| CFO | 179.0K | $293.6K | - | |
| Other | 146.0K | $239.4K | - | |
| Dir | 13.5K | $22.1K | - | |
| Dir | 13.5K | $22.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2016 | Eastern Capital Ltd | 10% Owner | Buy | 3,500,000 | $0.62 | $2,177,000.00 | +15.9% |